Wordt geladen...
Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
Itraconazole, a common triazole anti-fungal drug in widespread clinical use, has evidence of clinical activity that is of interest in oncology. There is evidence that at the clinically relevant doses, itraconazole has potent anti-angiogenic activity, and that it can inhibit the Hedgehog signalling p...
Bewaard in:
| Gepubliceerd in: | Ecancermedicalscience |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cancer Intelligence
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4406527/ https://ncbi.nlm.nih.gov/pubmed/25932045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.521 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|